CTEC Insider Trading

Insider Ownership Percentage: 0.94%
Insider Buying (Last 12 Months): £117,500
Insider Selling (Last 12 Months): £4,293,999.20

ConvaTec Group Insider Trading History Chart

This chart shows the insider buying and selling history at ConvaTec Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ConvaTec Group Share Price & Price History

Current Price: GBX 226.20
Price Change: Price Decrease of -1 (-0.44%)
As of 12/5/2025 05:27 AM ET

This chart shows the closing price history over time for CTEC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

ConvaTec Group Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/28/2025Jonny MasonInsiderBuy50,000GBX 235£117,500
8/7/2025Karim BitarInsiderSell1,250,000GBX 227£2,837,500
3/17/2025Karim BitarInsiderSell436,692GBX 256£1,117,931.52
3/14/2025Karim BitarInsiderSell132,253GBX 256£338,567.68
5/2/2023Karim BitarInsiderSell429,441GBX 216£927,592.56
3/9/2023Karim BitarInsiderSell27,833GBX 221£61,510.93
3/14/2022Karim BitarInsiderSell233,450GBX 179£417,875.50
See Full Table

SEC Filings (Institutional Ownership Changes) for ConvaTec Group (LON:CTEC)

50.89% of ConvaTec Group stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

ConvaTec Group logo
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Read More on ConvaTec Group

Today's Range

Now: GBX 226.20
Low: 225.40
High: 227.40

50 Day Range

MA: GBX 238.51
Low: 225.20
High: 249.20

52 Week Range

Now: GBX 226.20
Low: 218
High: 311.20

Volume

13,199,303 shs

Average Volume

16,503,621 shs

Market Capitalization

£4.49 billion

P/E Ratio

21.34

Dividend Yield

2.14%

Beta

0.64

Who are the company insiders with the largest holdings of ConvaTec Group?

ConvaTec Group's top insider investors include:
  1. Jonny Mason (Insider)
  2. Karim Bitar (Insider)
Learn More about top insider investors at ConvaTec Group.